(1)
Tjandraprawira, K. D.; Panigoro, R.; Hidayat, Y. M.; Susanto, H.; Sahiratmadja, E. Epidermal Growth Factor Polymorphism Most Prevalent in Stage II Cervical Carcinoma. Univ Med 2014, 33, 192-198.